News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.

Phio Pharmaceuticals files to sell 5.93M shares of common stock for holders [Seeking Alpha]

Form 3 Phio Pharmaceuticals For: Feb 19 Filed by: Deming David H

Form 8-K Phio Pharmaceuticals For: Feb 19

Form SCHEDULE 13G/A Phio Pharmaceuticals Filed by: CVI Investments, Inc.

Form 424B3 Phio Pharmaceuticals

Form EFFECT Phio Pharmaceuticals

Top News Decliners

2/11 Phio Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering -55.5%

3/31 Phio Pharmaceuticals Announces $4.0 Million Registered Direct Offering Priced At-the-Market -29.5%

3/11 Phio Pharma up 30% premarket on Medigene deal [Seeking Alpha] -25.1%

11/18 Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock -22.9%

11/21 Phio Pharma +51% premarket on expanding collaboration with Karolinska Institutet for RNAi immunotherapies [Seeking Alpha] -15.6%

1/10 Form 8-K Phio Pharmaceuticals For: Jan 10 -13.7%

12/13 Phio Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders -12.8%

11/13 Phio Pharmaceuticals Announces Proposed Public Offering of Common Stock -11.1%

3/26 Q4/2019 12/31/2019 EPS -4.690 ZacksConsensus N/A ActVsEst N/A - N/A -10.6%

2/10 Phio Pharmaceuticals Announces Compliance with Nasdaq Listing Requirements -10.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}